Current status and challenges of stem cell-based therapy for the treating of glioblastoma multiforme

Volume: 14, Issue: 1, Pages: 1 - 15
Published: Mar 1, 2021
Abstract
Glioblastoma (GB) is one of the most malignant types of central nervous system tumours, classified as grade IV by the World Health Organization. Despite the therapeutic advances, the prognosis is ominous, with a median survival of about 12-15 months post diagnosis. Although therapeutic options available can increase the survival, they are ineffective in treating patients with GB. Impairing factors such as the blood-brain barrier, cancer stem...
Paper Details
Title
Current status and challenges of stem cell-based therapy for the treating of glioblastoma multiforme
Published Date
Mar 1, 2021
Volume
14
Issue
1
Pages
1 - 15
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.